articleTop 10% cited
Potential hazard of pharmacokinetic interactions between lopinavir–ritonavir protease inhibitors and irinotecan
AIDS · 2005 · Vol. 19(17) · pp. 2043–2044
Giuseppe Corona✉(Johns Hopkins University)Emanuela Vaccher(University of Calgary)Giulio Cattarossi(Makerere University)Ivana Sartor(Johns Hopkins University)Giuseppe Toffoli(Johns Hopkins University)
Abstract
The IHDS may be a useful screening test to identify individuals at risk for HIV dementia in both the industrialized world and the developing world. Full neuropsychological testing should then be performed to confirm a diagnosis of HIV dementia.
HIV Research and TreatmentHIV/AIDS drug development and treatmentHIV-related health complications and treatmentsDementiaMedicineCohortLopinavirCohort studyMulticenter AIDS Cohort StudyRitonavirInternal medicineHuman immunodeficiency virus (HIV)Immunology
MeSH terms
AdultAgedCross-Cultural ComparisonDeveloping CountriesHumansMass ScreeningMiddle AgedNeuropsychological TestsPsychometricsPsychomotor PerformanceMental RecallSensitivity and SpecificityUgandaUnited StatesAIDS Dementia Complex
Citations
406
FWCI
3.19
field-weighted impact
References
9
Percentile
93%
vs. same field & year
Citations per year
Cited by
Updated research nosology for HIV-associated neurocognitive disorders
Neurology · 2007 · 2,586 citations
HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment
Journal of Neurology · 2017 · 336 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.